FORMULATION AND EVALUATION OF METOCLOPRAMIDE RAPIDLY DISINTEGRATING TABLETS
Abstract
Metoclopramide an effective antiemetic; acting on the CTZ, blocks apomorphine induced vomiting. Rapidly disintegrating tablets of metoclopramide hydrochloride were prepared by mass extrusion technique using three different superdisintegrants Sodium Starch Glycolate, Avicel Ph 102, L-HPC. Pre-compression parameters and post-compression parameters were evaluated for all the nine formulations. Angle of repose and % compressibility showed good flowability in all the formulations. Weight variation was found within limits and drug content of all the formulations was found in the range of 9.700 mg - 9.925 mg in each tablet. The hardness of all the formulations was almost uniform and possessed good mechanical strength with sufficient hardness. The wetting time in all the formulation was fast. Formulations F3 containing sodium starch glycolate 10% & F6 containing Avicel ph 102 10% tablets disintegrated rapidly to release the drug. In vitro release studies revealed that 96% of drug releases from SSG, MCC (90%), and L-HPC (85%) for all the formulations were within 15 min. Based on above results, three formulations F3, F6, F9 were selected for stability studies these formulations showed not much variation in any parameter even after the period of 30 days, formulations F3, F6, F9 are found to be stable and retained their original properties. Thus, it may be concluded that formulation containing sodium starch glycolate as superdisintegrants is fulfilling all the parameters satisfactorily. It showed excellent in vitro disintegration, in vitro dispersion time, compared to other superdisintegrants. And the rapidly disintegrating tablets can be prepared by mass extrusion technique
Â
DOI
https://doi.org/10.22270/jddt.v1i2.37Published
Abstract Display: 491
PDF Downloads: 736 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.